Grant of License 2. 1 Subject to the terms of this agreement, ITI hereby grants ITSI a worldwide, non-exclusive license to use, incorporate, market and sell the Licensed Technologies, in full or in part in Licensed Products. 2.2 For a period of [*] from the Effective Date of this Agreement, ITI agrees not to grant any new license to any direct competitor of ITSI as defined in Appendix B. ITSI understands that this [*] period is subject to continuing successful completion of required business development objectives listed in Appendix C. 2.3 ITSI agrees that, should it not meet any target defined in Attachment C, the [*] protection provided by ITI to ITSI under Article 2.2 will be relinquished. 2.4 ITSI warrants that the Licensed Technology and the Licensed Products will not be sold, either directly or indirectly to organizations outside of those involved in the inspection and testing undertaken on behalf of governments to monitor imports, exports and transit trade. 2.5 Nothing contained in this Agreement shall be construed as restricting ITSI's right to make Improvements to the Licensed Technology. If such Improvements use or relate to the Licensed Technologies, then such products which may be derived from the Licensed Products shall also be subject to the royalty payment under Section 5. ITSI agrees that ITI shall exclusively own all such Improvements, patentable or otherwise. 2.6 ITI is entitled to license its Technologies [*], except as defined in Section 2.2. 2.7 Except as otherwise provided herein, ITSI shall only make copies of the Licensed Technologies for the purpose of incorporating it in its Licensed Products. Unauthorized copying of the Licensed Technologies and Proprietary Information directly or indirectly by ITSI or by any of its employees or independent contractors, will constitute a fundamental and material breach of this Agreement. * Confidential portion omitted pursuant to a request for confidential treatment and filed separately with the Commission. -5- 2.8 ITSI shall have an unrestricted right to make copies of the Licensed Technologies for internal use, and for use by ITSI customers, for the purposes of demonstration and evaluation as well as for including it into its own Licensed Products. -6- 3.
Grant of License 2. 1 Exclusive License Roche hereby grants to CinCor an exclusive (even as to Roche), worldwide right and license under Roche Patent Rights, Roche Know-How, Roche’s interest in Joint Patent Rights and Joint Know-How, to research, have researched, develop, have developed, register, have registered, use, have used, make, have made, import, have imported, export, have exported, market, have marketed, distribute, have distributed, sell, have sold and otherwise exploit Compounds and Products in the Field in the Territory. This license shall include the right to sublicense in accordance with Sections 2.2 and 2.3 below.
Grant of License 2. 1 The Licensor hereby grants the Licensee an exclusive, irrevocable (subject to full payment of license fees and compliance with the terms of this Agreement), non-transferable license to make, use, distribute, market, sublicense (within the scope of license granted hereunder) or otherwise deal with the Products using the Patents and the Know How in the Contract Territory under the conditions that will be set forth in this Agreement. 2.2 The Licensor will neither itself nor through other licensees produce or let produce, distribute or let distribute the licensed Products in the Contract Territory, unless explicitly consented by the Licensee or otherwise determined by the parties by mutual agreement. 2.3 In any case, Licensor retains the right of research and development utilizing the Patents and Knowhow.
Grant of License 2. 1. Licensor hereby grants to Licensee, for the term of this Agreement, a royalty-bearing, worldwide right and license to, within the Field of Use: 2.1.1. use the Licensed Software internally for testing purposes; 2.1.2.
Grant of License 2. 1. The given License grants permission to use the Software on a specified number of Computers to assist in protecting them, from threats described in the User Manual, according to all technical requirements specified in the User Manual and according to the terms and conditions of this Agreement (the "License"). 2.2. If You have downloaded and installed a trial version of the Software and granted an evaluation license for the Software, You may use the Software only for evaluation purposes and only during the single applicable evaluation period, unless otherwise indicated, from the date of the initial installation. Any use of the Software for other purposes or beyond the evaluation period is strictly prohibited. 2.3. You have the right to use the Software for protection of the number of Computer(s) as mentioned in Your License. 2.4. You have the right to make a copy of the Software solely for backup purposes and only to replace the legally owned copy if such is, lost or becomes unusable, this backup copy cannot be used for other purposes. It must be destroyed when You lose the right to use the Software or when Your license expires or is terminated for any other reason according to the legislation in force in the country of Your principal residence or in the country where You are using the Software. 2.5. From the time of the Software activation, You have the right to receive the following services from PRO32 or its partners for the period specified in the License. 2.5.1.Updates of the Software via the internet when and as the Company publishes them on its website or through other online services. Any Updates that You may receive become part of the Software and the terms and 2. Предоставление лицензии 2.1. Предоставленная Лицензия даёт разрешение на использование Программного обеспечения на определенном количестве Компьютеров для оказания помощи в их защите от угроз, описанных в Руководстве пользователя, в соответствии со всеми техническими требованиями, указанными в Руководстве пользователя, и в соответствии с условиями и положениями настоящего Соглашения ("Лицензия"). 2.2. Если Вы загрузили и установили пробную версию Программного обеспечения и предоставили ознакомительную лицензию на Программное обеспечение, Вы можете использовать Программное обеспечение только в ознакомительных целях и только в течение единственного применимого периода ознакомления, если не указано иное, с даты первоначальной установки. Любое использование Программного обеспечения для друг...
Grant of License 2. 1.1 Subject to the terms and conditions of this Agreement, Transgenomic hereby grants to Licensee, solely to the extent of Transgenomic’s legal right to do so, a personal, non-exclusive, non-transferable, non-sublicensable license solely under the Long QT Patents to: (i) undertake or make (but not to have undertaken or made) Long QT Tests in the Territory; (ii) use the Long QT Tests undertaken or manufactured pursuant to Section 2.1.1(i) to (a) conduct internal, not-for-profit research concerning the Long QT Genes or their associated RNAs or polypeptides (provided that, for clarity, such research may not be carried out for any commercial purposes or carried out on behalf of or for the benefit of any third party other than a patient as provided below), (b) screen for any mutations within one or more of the Long QT Genes or their functional products (e.g. RNAs or proteins), and (c) carry out diagnoses based on the screening set forth in Section 2.1.1(ii)(b) hereof; (iii) advertise the screening and diagnosis services set forth in Sections 2.1.1(ii)(b) and 2.1.1(ii)(c) hereof solely in the Territory; and/or (iv) sell the screening and diagnosis services set forth in Sections 2.1.1(ii)(b) and 2.1.1(ii)(c) solely in the Territory, in all cases only where all of the following conditions are met: a. the Long QT Tests are performed by Licensee and otherwise sold by Licensee at or below cost; b. the screening and diagnosis services set forth in Sections 2.1.1(ii)(b) and 2.1.1(ii)(c) are performed on research subjects or patients who are citizens or residents of Canada, who are refugees in Canada, or who are present in Canada for reasons other than receiving medical services, purchasing medical or pharmaceutical products or services, or otherwise receiving the benefit of the Canadian healthcare system; and c. the Long QT Tests are performed pursuant to a healthcare professional’s recommendation or direction. 2.1.2
Grant of License 2
